DUBLIN–(BUSINESS WIRE)–The “Successful Medical Writing – from Protocol to CTD Training Course (Mar 23rd – Mar 24th, 2026)” training has been added to ResearchAndMarketsDUBLIN–(BUSINESS WIRE)–The “Successful Medical Writing – from Protocol to CTD Training Course (Mar 23rd – Mar 24th, 2026)” training has been added to ResearchAndMarkets

Successful Medical Writing from Protocol to CTD Training Course: Understand International Guidelines and Standards (Mar 23rd – Mar 24th, 2026) – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Successful Medical Writing – from Protocol to CTD Training Course (Mar 23rd – Mar 24th, 2026)” training has been added to ResearchAndMarkets.com’s offering.

Success in the pharmaceutical industry depends on the speed and efficiency of new drug approvals.

This process largely relies on the quality of documentation submitted to the regulatory authorities, and a high standard of medical writing plays a vital role in ensuring a positive outcome. This intensive three-day medical writing course will help you to improve your skills and achieve this standard.

Who Should Attend:

The course will be of interest to all those in the pharmaceutical industry who prepare research reports and documentation intended for regulatory authorities. Although the focus of the seminar is on clinical research, many of the principles will also apply to other types of reports, including pre-clinical, CMC and veterinary documentation. The practical training will benefit not only those new to medical writing, but also those wishing to perfect their existing writing skills, including full-time medical writers and those who only occasionally write research documentation or regulatory submissions.

Benefits of attending

  • Gain in-depth knowledge on general writing and data presentation skills, specifically in the kind of documents most frequently encountered in clinical research
  • Understand the international guidelines and standards
  • Explore both the theoretical and practical aspects of writing for regulatory authorities through illustrative examples

Certifications

  • CPD: 12 hours for your records
  • Certificate of completion

Key Topics Covered:

Day 1 – Fundamentals of Regulatory Medical Writing

Introduction to Regulatory Medical Writing

  • Overview of medical writing in the pharmaceutical industry
  • Types of documents
  • Project management
  • Working cross-functionally
  • Document reviews
  • Quality checks

Regulatory environment and guidelines

  • Regulatory agencies and key regulatory guidelines
  • Drug development lifecycle and regulatory milestones

Regulatory documents

  • What are they and why are they needed?
  • Developing the protocol and ICFs
  • Developing the CSR
  • Developing the Investigator’s Brochure
  • Developing the DSUR

Day 2 – Scientific Advice and Marketing Applications

Briefing documents

  • What are they?
  • Why are they needed?
  • How are they developed?

Importance of real-world evidence and patient-centred outcomes

The Common Technical Document

  • Introduction to clinical submission dossiers
  • Writing the clinical overview & the clinical summary

Speakers:

Cheryl Roberts-Vitalis

BioMarin Pharmaceutical Inc.

Cheryl is currently the Global Head of Medical Writing at BioMarin Pharmaceutical Inc., and specialises in medical writing for serious and life-threatening rare diseases. She joined the pharmaceutical industry in 2001 in drug development, and continued in positions in medical editing and medical writing in both the pharmaceutical and consultancy industry. She holds a degree in Medical Biology and a Masters in Neuroscience. Cheryl has been an approved workshop leader for the European Medical Writers Association since 2015 and gives training on subgroup analyses and orphan medicinal products.

For more information about this training visit https://www.researchandmarkets.com/r/2lk8xk

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Fed Decides On Interest Rates Today—Here’s What To Watch For

Fed Decides On Interest Rates Today—Here’s What To Watch For

The post Fed Decides On Interest Rates Today—Here’s What To Watch For appeared on BitcoinEthereumNews.com. Topline The Federal Reserve on Wednesday will conclude a two-day policymaking meeting and release a decision on whether to lower interest rates—following months of pressure and criticism from President Donald Trump—and potentially signal whether additional cuts are on the way. President Donald Trump has urged the central bank to “CUT INTEREST RATES, NOW, AND BIGGER” than they might plan to. Getty Images Key Facts The central bank is poised to cut interest rates by at least a quarter-point, down from the 4.25% to 4.5% range where they have been held since December to between 4% and 4.25%, as Wall Street has placed 100% odds of a rate cut, according to CME’s FedWatch, with higher odds (94%) on a quarter-point cut than a half-point (6%) reduction. Fed governors Christopher Waller and Michelle Bowman, both Trump appointees, voted in July for a quarter-point reduction to rates, and they may dissent again in favor of a large cut alongside Stephen Miran, Trump’s Council of Economic Advisers’ chair, who was sworn in at the meeting’s start on Tuesday. It’s unclear whether other policymakers, including Kansas City Fed President Jeffrey Schmid and St. Louis Fed President Alberto Musalem, will favor larger cuts or opt for no reduction. Fed Chair Jerome Powell said in his Jackson Hole, Wyoming, address last month the central bank would likely consider a looser monetary policy, noting the “shifting balance of risks” on the U.S. economy “may warrant adjusting our policy stance.” David Mericle, an economist for Goldman Sachs, wrote in a note the “key question” for the Fed’s meeting is whether policymakers signal “this is likely the first in a series of consecutive cuts” as the central bank is anticipated to “acknowledge the softening in the labor market,” though they may not “nod to an October cut.” Mericle said he…
Share
BitcoinEthereumNews2025/09/18 00:23
US Dollar Index rises above 98.50 on US-Venezuela tensions, eyes ISM PMI data

US Dollar Index rises above 98.50 on US-Venezuela tensions, eyes ISM PMI data

The post US Dollar Index rises above 98.50 on US-Venezuela tensions, eyes ISM PMI data appeared on BitcoinEthereumNews.com. The US Dollar Index (DXY), which measures
Share
BitcoinEthereumNews2026/01/05 12:29
The Role of Reference Points in Achieving Equilibrium Efficiency in Fair and Socially Just Economies

The Role of Reference Points in Achieving Equilibrium Efficiency in Fair and Socially Just Economies

This article explores how a simple change in the reference point can achieve a Pareto-efficient equilibrium in both free and fair economies and those with social justice.
Share
Hackernoon2025/09/17 22:30